【摘 要】
:
Glycine-Phenylalanine-Leucine-Glycine,known as tetrapeptide Gly-Phe-Leu-Gly and can be degraded in the presence of cathepsin B,which is one of the most prominent proteases present in normal cells and
【机 构】
:
School of Chemical Biology and Pharmaceutical Sciences, Capital Medical University
【出 处】
:
首都医科大学第四届研究生学术论坛第二分论坛
论文部分内容阅读
Glycine-Phenylalanine-Leucine-Glycine,known as tetrapeptide Gly-Phe-Leu-Gly and can be degraded in the presence of cathepsin B,which is one of the most prominent proteases present in normal cells and tissues according to the recent research.The expression of cathepsin B is greatly increased in human tumors such as prostate,breast,colon,esophageal,gastric,lung,ovarian,thyroid carcinomas,gliomas and melanomas.\So we can exploit the free carboxyl group in Gly-Phe-Leu-Gly to conjugate drugs,and it hydrolysis to release drugs while reaching the tumor cells,this ptovides a controlled way to target drugs to the tumor tissues to a certain extent.Lipoic acid is reported to have very high health care and medical value and can protect thiol enzyme from heavy metal ions.Lipoic acid has applications in stabilization of blood glucose levels,strengthen liver function and elimination of fatigue.Moreover,in comparison to monothiol-ligands,Lipoic acid is bidentate-thiols so that can function as coordinate bonding and strongly modify to the metal materials such as gold,silver,iron et al.So in this study we conjugate lipoic acid with Gly-Phe-Leu-Gly by amide linkage to creat a new compound named as LA-Gly-Phe-Leu-Gly,which can both have the advantages of lipoic and Gly-Phe-Leu-Gly,and may become a potential drug delivery vehicle in future.
其他文献
目的:探讨粒细胞-巨噬细胞集落刺激因子(GM-CSF)作为免疫佐剂对登革病毒E蛋白免疫保护的影响,评估GM-CSF作为免疫佐剂的多面性。方法 实验共设3组,分别为E蛋白组、E蛋白+pCAG-GM组(表达GM-CSF)和对照组,采用肌肉注射和足垫注射两种方式进行免疫。分别利用ELISA和PRNT检测血清总IgG水平和中和抗体水平,ELISPOT检测细胞因子的分泌,攻毒实验检测动物保护率。结果 ELI
抑制尿激酶型纤溶酶原激活物(u-PA)可以阻止一系列病理过程,如:肿瘤细胞粘附、迁移和在转移部位的生长.本文设计合成并评价了新的u-PA抑制剂:SS,RR,RS和SR 3-(4-氨基丁基)-6-(1H-吲哚-3-甲基)哌嗪-2,5-二酮(AIPZ).手性高效液相色谱显示,它们的纯度接近100%.将这些类似物和u-PA活性位点进行对接,均得到较高的分数(118-134).FT-MS表明,在水溶液中A
[研究目的]本实验旨在探索新生大鼠胸髓节段突触网络形成及发育过程,并运用MED64平面微电极记录技术着重研究兴奋性突触后场电位(field excitatory postsynaptic potential,fEPSP)随时间进展兴奋性变化的电生理学特点及神经药理学特性.[研究方法]分别制备出生后(postnatal,P) 24小时内(P0)、1天(P1)、3天(P3)、5天(P5)、7天(P7)
血管栓塞是中风症候的一个主要风险因素,因此治疗血管栓塞的新型药物一直备受关注.本文举出抑制P-选择素表达的新化合物DHDMIQK (KAP),即N-[(S)-6,7-二羟基-1,1-二甲基-1,2,3,4-四氢异喹啉-3-羰基]-赖氨酸(脯氨酸-丙氨酸-赖氨酸),该化合物的设计利用了计算机辅助筛选与介观动力学模拟下的分子对接技术,体外试验中,1 nM的DHDMIQK (KAP)即可有效下调P-选择
本研究是为了探究药品中维生素D含量测定的简单可行方法.采用高效液相色谱(HPLC)法,C18柱为固定相,甲醇:乙腈=9:1为流动相,紫外检测波长为265nm,维生素D2和维生素D3达到基线分离.维生素D2和维生素D3的最低定量检出限均为0.01 mg/L,且浓度在0.01 mg/L至0.5mg/L时有良好的线性关系.,将0.1 9氨基酸钙胶囊样品加于5mL甲醇中超声提取45 min,上清液过0.4
炎症在肿瘤中起危害作用,自由基损伤可以使癌症患者的状态更严重的.能够抑制炎症和清除自由基的抗癌剂极大的吸引了我们兴趣.以此为目标,我们得到了一种新型的扦插剂BPIC.分子对接的结果表明,BPIC与阿霉素相比有着相似的得分和特征.对8株肿瘤细胞的抗增值结果筛查发现,BPIC与阿霉素对S180肿瘤细胞有着等同的敏感性.抗肿瘤实验表明BPIC的活性是阿霉素的两倍.BPIC在I μmol/kg的剂量下,可
尽管甲氨蝶呤(MTX)/米托蒽醌(MIT)的常规聚形可与其他抗癌药物形成多样混合式结构,但是在治愈率、生存期以及系统毒性等问题上仍需进一步改善.为此本文设计合成了以氨基基团修饰的纳米介孔氧化硅(MSNN)-MTX/MIT.在制备时,采用氨基基团修饰纳米介孔氧化硅(MSNs)表面形成MSNN,并用MTX对MSNN表面上的氨基进行共价修饰生成MSNN-MTX,将MIT装载于MSNN-MTX的表面孔隙中
为了提高抗肿瘤药物的疗效,胸腺五肽偶联(1S,3S)-1-甲基-四氢-β-咔啉-3-羧酸(MTCTP5)被设计合成并对其进行了研究。针对小鼠和大鼠进行的药理学活性研究显示,MTCTP5能够呈剂量依赖性地减缓肿瘤生长,抑制炎症反应,阻止血栓形成。在水及小鼠血浆中,MTCTP5可形成直径在47-137nm间稳定的纳米微粒,不仅其抗肿瘤、抗炎活性和抗血栓活性分别比(1S,3S)-1-甲基-四氢-β-咔啉
基于先前的研究,人们知道环己烷-1,4-二酮,哌嗪和β-咔啉是DNA嵌入剂重要的结构片断,β-咔啉-3-羧酸是π-π堆叠型DNA嵌入剂,β-咔啉衍生物可以形成纳米颗粒.本文假设(2S,5S)-四氢吡嗪并[1,2:1,6]-二{2,3,4,9-四氢-1H-吡啶并[3,4-b]吲哚}-1,4-二酮(THPDTPI)为π-π堆叠型纳米嵌入剂.THPDTPI可由两分子3S-1,2,3,4-四氢-β-咔啉-
In recent years,the cancer is still one of the diseases that threaten humans lives.As an antitumor antibiotic,Doxorubicin (DOX) has wide anticancer spectrum and strong activity.But its low selectivity